Introduction {#Sec1}
============

Circadian clocks are cell-autonomous molecular oscillators that drive daily rhythms of physiology and behaviour. In mammals, the clock of the suprachiasmatic nucleus (SCN) in the brain drives the rest--activity cycle and modulates physiology through autonomic and neuroendocrine control of visceral organ function \[[@CR1]\]. Many peripheral tissues have intrinsic clocks, but at present there is only limited information about their functions \[[@CR2]\].

Mice with germ-line mutations of circadian clock function have abnormal glucose homeostasis, regardless of whether the mutation affects positive (*Clock* \[[@CR3]\] or *Bmal1* \[also known as *Arntl*\]^*−/−*^ \[[@CR2], [@CR4]\]) or negative (*Per1*^*−/−*^, *Per2*^*−/−*^ \[[@CR2]\]) elements of the clock feedback loop. This suggests that glucose homeostasis abnormalities arise from disrupted clock function rather than from an unrelated function of a particular clock gene. Because these mice lack clock function in all tissues, abnormal glucose homeostasis could have arisen from (1) a defect of the SCN clock (and the consequent abnormal activity and feeding), (2) other brain clocks or (3) clocks of peripheral tissues. *Bmal1*^*−/−*^ mice have significantly reduced circulating insulin \[[@CR2]\], so it is plausible that a clock within the pancreas, particularly in the insulin-producing beta cells of the islets of Langerhans, might be crucial for glucose homeostasis.

Methods {#Sec2}
=======

**Mice** Mice (*Pdx1-Cre*) were provided by D. Melton (Harvard University, Department of Molecular and Cellular Biology, Cambridge, MA, USA) \[[@CR5]\]. We generated *Bmal1*^*lox/lox*^ \[[@CR6]\] and *Bmal1-Luc* mice \[[@CR7]\]. Mice (hybrid C57BL/6;129 background) were entrained to a 12 h light--dark cycle for 2 weeks prior to experiments. Genotyping was performed as described \[[@CR6]\]. Studies were performed in accordance with a protocol approved by the Harvard Medical School Standing Committee on Animals.

**Real-time recordings of circadian bioluminescence** Explants of pancreas from *Bmal1-Luc* circadian reporter mice were dissected, placed in medium (2 ml DMEM, supplemented with protease inhibitors, 10% \[vol./vol.\] FBS, 100 U/ml penicillin, 100 μg/ml streptomycin and 250 μmol/l [d]{.smallcaps}-luciferin), cultured and monitored for bioluminescence as described \[[@CR7]\].

**Glucose and insulin tolerance tests** Glucose and insulin tolerance tests, and insulin determination were performed as described \[[@CR2]\]. For glucose tolerance tests across the circadian cycle, manipulations were performed under dim red light.

**Immunohistochemistry and in situ hybridisation** Mice with *Bmal1* deleted from the pancreas (Panc-*Bmal1*^*−/−*^) and *Pdx1-Cre* littermates (*n* = 3 for each) were killed and the pancreas dissected into 4% formaldehyde in PBS. Pancreases were post-fixed (2 h, 4°C), fixative was removed by washes in PBS and tissue was cryoprotected overnight (4°C, 30% \[wt/vol.\] sucrose in PBS). Pancreases were then embedded and frozen, and 10 μm sections were cut on a cryostat, dried and stored at −80°C.Insulin immunohistochemistry was performed using guinea pig anti-insulin (1:700; Dako, Glostrup, Denmark), followed by donkey anti-guinea pig secondary antibody (1:200; Invitrogen, Carlsbad, CA, USA). For double-label immunostaining with in situ hybridisation, fluorescence in situ hybridisation was performed as described in the Electronic supplementary material (ESM) [Methods](#MOESM1){ref-type=""}. Estimation of islet number was performed by counting the number of islets (identified by insulin immunostaining) per 10 μm section of four to seven sections per mouse, using three mice per genotype. Islet area and staining intensity (12--14 islets per genotype) were measured by circling islets in insulin immunofluorescence images and measuring area and mean grey value with ImageJ software (ESM [Methods](#MOESM1){ref-type=""}).

**Glucose-stimulated insulin secretion** Pancreatic islets were isolated from mice and incubated overnight for recovery in DMED containing 1 mg/ml glucose (Sigma, St Louis, MO, USA) and 10% FBS. For glucose-stimulated insulin secretion, isolated islets were incubated in KRB containing bicarbonate and HEPES (KRBH; 129 mmol/l NaCl, 4.8 mmol/l KCl, 2.5 mmol/l CaCl~2~, 1.2 mmol/l KH~2~PO~4~, 1.2 mmol/l MgSO~4~, 5 mmol/l NaHCO~3~, 10 mmol/l HEPES, 0.1% (vol./vol.) BSA) with 2.8 mmol/l [d]{.smallcaps}-glucose for a 1 h for wash. Triplicates of ten islets were then incubated for 75 min in KRBH buffer containing either low (2.8 mmol/l) or high (16.7 mmol/l) [d]{.smallcaps}-glucose. Insulin in supernatant fractions was measured using an ELISA kit (Mouse Insulin Ultrasensitive; Alpco Diagnostics, Salem, NH, USA). For insulin content, groups of ten isolated islets were incubated overnight at −80°C in acidic ethanol (1.5% \[vol./vol.\] HCl in 70% \[vol./vol.\] ethanol), followed by centrifugation (20,000 g, 10 min) and measurement of insulin content as above.

**Statistical analysis** Statistical analysis was performed by ANOVA or Student's *t* test, as indicated. A value of *p* \< 0.05 was considered significant.

Results {#Sec3}
=======

To determine whether the mouse pancreas contains a circadian clock, as reported in rats \[[@CR8], [@CR9]\], we cultured pancreas explants from *Bmal1-Luc* mice, a circadian reporter line \[[@CR7]\]. The explants exhibited robust circadian rhythms of bioluminescence (Fig. [1a](#Fig1){ref-type="fig"}), demonstrating the presence of an autonomous clock. We detected co-expression of insulin and core clock component mRNAs (Fig. [1b](#Fig1){ref-type="fig"}), strongly suggesting that the insulin-producing beta cells of islets are among the pancreatic cell-types possessing an intrinsic clock. Fig. 1Glucose intolerance and defective insulin secretion in mice selectively lacking an intrinsic circadian clock of the pancreas. **a** Presence of an autonomous circadian clock in the pancreas. Real-time bioluminescence output of an explanted pancreas from a *Bmal1*-*Luc* circadian reporter mouse \[[@CR7]\]. **b** Combined immunohistochemistry and fluorescence in situ hybridisation to pancreas sections showing co-presence of insulin protein (red) and circadian clock component mRNA *Per1* and *Bmal1* as labelled (both green) in pancreatic islets. Punctate appearance of fluorescence signal for mRNAs is typical. Hoechst stain (blue) shows positions of cell nuclei. Arrows, double-labelled cells. **c** Glucose tolerance test performed at Zeitgeber time (ZT) 4.5 h in mice selectively lacking circadian clocks in the pancreas (Panc*-Bmal1*^*−/−*^; C57BL/6-129 hybrid) and littermate control genotypes. Mice used: *Bmal1*^*lox/lox*^, *Bmal1* conditional allele homozygote without *Cre*; *Pdx1-Cre*, single copy of *Cre* transgene and wild-type *Bmal1*. *p* \< 0.001 (ANOVA). **d** Insulin tolerance tests, as above (**c**). No significant difference between genotypes (ANOVA). **e** Serum insulin concentrations at the indicated times after glucose administration. *p* \< 0.02 (ANOVA). **f** Circadian profile of glucose tolerance for the three genotypes (*n* = 9--10 per genotype). **g** Quantification of circadian glucose tolerance curves shown above (**f**). CT, circadian time for all groups as for dark grey bars. **c--g** Values are mean±SEM. Light grey, *Pdx1-Cre*; dark grey, *Bmal1*^*lox/lox*^; black, Panc-*Bmal1*^*−/−*^

We next tested the hypothesis that an intrinsic circadian clock of the pancreas is important for glucose homeostasis. To generate mice with selective genetic ablation of clock function in the pancreas (Panc*-Bmal1*^*−/−*^ mice), we crossed *Bmal1* conditional mice \[[@CR6]\] with the *Pdx1-Cre* line \[[@CR5]\]. As previously reported, *Pdx1-Cre* showed recombination activity throughout the pancreas and scattered activity in the duodenum, but no detectable activity in other peripheral tissues (ESM Fig. [1](#MOESM2){ref-type=""}a). We detected no *Cre* activity in the SCN or in most of the brain, but did detect activity in the arcuate nucleus, ventromedial hypothalamus and dorsomedial hypothalamus (ESM Fig. [1](#MOESM2){ref-type=""}b). Because these hypothalamic structures are well known to contribute to the neural regulation of glucose metabolism, this finding makes it essential to document a physiological defect in isolated pancreatic islets before concluding that a glucose homeostasis defect caused by *Pdx1-Cre* recombination is of pancreatic origin. In Panc-*Bmal1*^*−/−*^ mice, deletion of the conditional *Bmal1* allele (ESM Fig. [2](#MOESM3){ref-type=""}a) was consistent with the results of the indicator cross (ESM Fig. [1](#MOESM2){ref-type=""}a). As expected, the protein brain, muscle Arnt-like 1 (BMAL1) was selectively lost from the pancreas (ESM Fig. [2](#MOESM3){ref-type=""}b).

Unlike *Bmal1*^*−/−*^ mice lacking BMAL1 in all tissues \[[@CR2]\], Panc-*Bmal1*^*−/−*^ mice exhibited normal locomotor activity, feeding behaviour, adiposity and body weight (ESM Fig. [3](#MOESM4){ref-type=""}). Panc*-Bmal1*^*−/−*^ mice had an abnormality of glucose homeostasis essentially identical to that of *Bmal1*^*−/−*^ mice \[[@CR2]\], characterised by severe glucose intolerance, normal responsiveness to insulin and defective insulin secretion in response to glucose (Fig. [1c--e](#Fig1){ref-type="fig"}). Panc-*Bmal1*^*−/−*^ mice exhibited intolerance to glucose throughout the circadian cycle, but a modest circadian modulation of glucose tolerance similar to that of controls persisted (Fig. [1f, g](#Fig1){ref-type="fig"}). Thus at least one clock outside the pancreas contributes to the circadian regulation of circulating glucose. The most likely candidate is the SCN clock, thought to modulate insulin secretion or sensitivity via autonomic efferents \[[@CR1]\].

Pancreatic islets of Panc-*Bmal1*^*−/−*^ mice were indistinguishable in appearance from those of littermate *Pdx1-Cre* controls (Fig. [2a](#Fig2){ref-type="fig"}) and no significant difference was found between genotypes in the numbers of islets, mean size of islets or intensity of islet staining for insulin (Fig. [2b--d](#Fig2){ref-type="fig"}). Thus it is unlikely that the glucose intolerance and defective insulin secretion of Panc-*Bmal1*^*−/−*^ mice reflects a gross abnormality of islet development. Isolated, cultured islets from Panc-*Bmal1*^*−/−*^ mice secreted significantly less insulin in low and high glucose than islets from littermate *Pdx1-Cre* controls (Fig. [2e](#Fig2){ref-type="fig"}). There was no significant difference between genotypes in the total content of insulin per islet (Fig. [2f](#Fig2){ref-type="fig"}), indicating that the phenotype results from a defect in insulin secretion rather than insulin synthesis. Fig. 2Defective glucose-stimulated insulin secretion from pancreatic islets of mice selectively lacking an intrinsic circadian clock of the pancreas. **a** Normal general appearance of pancreatic islets in Panc-*Bmal1*^*−/−*^ mice vs *Pdx-Cre*. Immunofluorescence micrographs of pancreas sections were stained for insulin. **b--d** No significant differences were detected between Panc-*Bmal1*^*−/−*^ mice and littermate controls in variables reflecting the number, size or insulin expression of pancreatic islets (Student's *t* test). **e** Defective insulin secretion from isolated islets of Panc-*Bmal1*^*−/−*^ mice under low and high glucose conditions, ^†^*p* = 0.03, ^‡^*p* = 0.002 (Student's *t* test). **f** No significant difference in total insulin content of isolated islets from Panc-*Bmal1*^*−/−*^ mice and control littermates (Student's *t* test). **b--f** Values are mean±SEM. Light grey, *Pdx1-Cre*; black, Panc-*Bmal1*^*−/−*^

Discussion {#Sec4}
==========

Previous reports of clock gene expression in the pancreas \[[@CR8]\] and rhythmic insulin release from isolated islets \[[@CR9]\] suggested that a pancreatic clock regulates glucose homeostasis in vivo, a hypothesis our experiments have explicitly tested. Our results indicate that the *Bmal1* gene, and probably circadian clock function, is required in the pancreas for normal insulin secretion and normal glucose homeostasis. The glucose intolerance of Panc-*Bmal1*^*−/−*^ mice is essentially identical to that of *Bmal1*^*−/−*^ mice \[[@CR2]\], indicating that the loss of SCN clock function and consequent behavioural abnormalities in *Bmal1*^*−/−*^ mice contribute little, if anything to the glucose homeostasis phenotype. A similar, independent analysis has recently been reported \[[@CR10]\].

We do not know the molecular mechanism underlying the defect in insulin release in Panc-*Bmal1*^*−/−*^ mice. The known role of clocks in regulating cell-autonomous gene expression suggests that a circadian clock within pancreatic beta cells regulates levels of one or more proteins of the glucose-sensing and/or insulin secretion pathways. In the absence of BMAL1, levels of one or more such proteins might fall below the usual circadian trough value, limiting insulin secretion. Our results provide evidence for a previously-unrecognised molecular regulator of pancreatic glucose-sensing and/or insulin secretion.
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Sites of Cre recombinase activity from the *Pdx1-Cre* transgene in *R26r* indicator mice. **a** Peripheral tissue beta galactosidase histochemistry of the indicated tissue sections confirming the previously reported pattern of *Pdx1-Cre* activity. **b** Beta galactosidase histochemistry of indicated coronal brain sections. No activity was detected in the SCN or in the brain generally, but scattered activity was detected in the arcuate nucleus (AN), dorsomedial hypothalamus (DMH) and ventomedial hypothalamus (VMH) as indicated. Images are representative of those derived from three mice (PDF 54 kb)
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Analysis of the *Bmal1* gene and BMAL1 protein in Panc-*Bmal1−/−* mice. **a** PCR analysis of genomic DNA from the indicated tissues from mice of the indicated genotypes (lane designations same for each tissue). **b** Western blot analysis of BMAL1 protein from nuclear extracts of the indicated tissues from mice of the indicated genotypes. Nuclear protein SAP155 served as a loading control. Trace BMAL1 in pancreas sample is likely to have derived from vascular cells within the pancreas, in which recombination by *Pdx1-Cre* should not occur (PDF 75 kb)

###### 

Panc-*Bmal1−/−* mice and littermate controls were indistinguishable in behaviour, adiposity and body weight**. a** Representative double-plotted actograms for locomotor activity (running wheel behaviour) and feeding behaviour (food approach beam-breaks) of mice of the indicated genotypes. Horizontal axes represent time (2 × 24 h), successive lines (top to bottom) on vertical axes represent successive days. Tick marks represent running wheel revolutions (\>0 per 6-min time bin, left) or food-approach beam-breaks. **b** Quantification of population data for the indicated variables for locomotor activity or feeding behaviour as indicated. Black bars, Panc*-Bmal1−/−* mice (locomotor activity *n* = 25, feeding behaviour *n* = 9); light grey bars, littermate *Pdx1-Cre* controls (locomotor activity *n* = 17, feeding behaviour *n* = 10). Values are mean±SEM. No significant differences between genotypes were observed for any variable (Student's *t* test). **c** No significant differences were detected between genotypes for body composition at 24 weeks of age (% fat) or (**d**) bodyweight at 2 and 7 months of age. Genotypes labelled as above (**b**). Values are means±SEM. **c, d***n* = 10 and 8 respectively for Panc-*Bmal1−/−* mice and littermate *Pdx1-Cre* controls (PDF 116 kb)
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